IMATINIB
Manner of administration:Oral
Restriction
Indication: Acute lymphoblastic leukaemia
Treatment phase: Induction and Consolidation therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 2 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 17889)
Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment - first-line therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 17886)
Indication: Malignant gastrointestinal stromal tumour
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 2 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 17826)
Indication: Acute lymphoblastic leukaemia
Treatment phase: Maintenance of first complete remission
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 2 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 17884)
Indication: Dermatofibrosarcoma protuberans
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction
Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Initial treatment - first-line therapy
Restriction
Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Initial treatment - first-line therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 2 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction
Indication: Malignant gastrointestinal stromal tumour
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 2 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction
Indication: Dermatofibrosarcoma protuberans
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 17829)
Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment
Restriction (Streamlined authority code: 17830)
Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 2 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||
Manner of administration:Oral
Restriction
Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Initial treatment - first-line therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $560.42 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Imatab | |||||